Ultrasonic COmparison of Salivary Glands in Autoimmune Diseases (COUGAR)
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity Hospital, Brest
About this trial
Prospective multicenter cross-sectional study evaluating ultrasound of the main salivary glands (2 parotid and 2 submandibular) in patients with Sjögren's disease compared with patients with other connective diseases (rheumatoid arthritis (RA), lupus, scleroderma) and control patients (patient with dry syndrome without the above-mentioned autoimmune disease).
Eligibility criteria
Qualifiers
Major patients
Patients fulfilling Sjogren criteria (2012 and 2016 American-European criteria) or Lupus according to ACR 2019 criteria or RA according to ACR/EULAR 2010 criteria or scleroderma according to ACR-EULAR 2013 classification criteria or control patient (patient with dry syndrome felt without pre-cited autoimmune disease).
Disqualifiers
Uncooperative patient who has refused to participate in the study.
Patients unable to understand the protocol, under guardianship or curatorship.
Patients not affiliated to the French Social Security system.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
501 Participants
are grouped into 3 trial groupsSponsors and collaborators
University Hospital, Brest
Lead sponsor
CHRU de Brest (Brest University Hospital)
Collaborator
Source ClinicalTrials.gov